The latter is characterized by senescence in CD8+ T-cells, and NK cells leading to loss of their cytotoxic activity, while senescence in CD4+ T-cells that exert a multifaceted role in cancer immunity, leads to a diminished pool of functional T-cells incapable of responding to new antigens [83–85]. The gene discussed is CD8A; the disease is cancer.